CAS 114-07-8: Eritromicina
Descripción:Eritromicina es un antibiótico macrólido que se utiliza principalmente para tratar infecciones bacterianas. Se deriva de la bacteria Saccharopolyspora erythraea y es efectivo contra una variedad de bacterias Gram-positivas y algunas Gram-negativas. La estructura química de Eritromicina presenta un gran anillo de lactona, que es característico de los macrólidos, junto con varios moieties de azúcar que contribuyen a su solubilidad y actividad biológica. Eritromicina actúa inhibiendo la síntesis de proteínas bacterianas, evitando así el crecimiento y la reproducción de las bacterias. Se utiliza comúnmente en el tratamiento de infecciones del tracto respiratorio, infecciones cutáneas y ciertas infecciones de transmisión sexual. Eritromicina está disponible en varias formulaciones, incluyendo tabletas orales, ungüentos tópicos y preparaciones intravenosas. Aunque generalmente es bien tolerado, puede causar efectos secundarios como trastornos gastrointestinales y puede interactuar con otros medicamentos debido a sus efectos sobre las enzimas hepáticas. Se ha observado resistencia a Eritromicina en algunas cepas bacterianas, lo que puede limitar su efectividad en ciertas infecciones.
Fórmula:C37H67NO13
InChI:InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1
Clave InChI:InChIKey=ULGZDMOVFRHVEP-RWJQBGPGSA-N
SMILES:O=C1OC(CC)C(O)(C)C(O)C(C(=O)C(C)CC(O)(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)C(OC3OC(C)C(O)C(OC)(C)C3)C1C)C
- Sinónimos:
- (2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
- (2S,3R,4S,6R)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl propanoate (non-preferred name)
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
- (3R,7R,9R,11R,13S,14R)-6-{[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
- 6-{[4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)
- Abboticin
- Abomacetin
- Ak-Mycin
- Aknin
- Ver más sinónimos
- Dotycin
- Drmysin
- E-Base
- E-mycin
- E.E.S
- EMU
- Emgel
- Ergel
- Eritocina
- Eritrex
- Eritrocina
- Eritromed
- Eritromicina
- Ermycin
- Erthrogran
- Ery Derm
- Ery-Ped
- Ery-Tab
- EryDerm
- Eryacne
- Eryc
- Erycen
- Erycette
- Erycin
- Erycinum
- Erygel
- Erymax
- Erytab
- Erythro
- Erythrocin
- Erythrogran
- Erythroguent
- Erythromast
- Erythromast 36
- Erythromid
- Erythromycin A
- Erythromycine
- Ilocap
- Ilosone
- Ilotycin
- Inderm
- L-alpha-Egg-phosphatidylcholine
- Nsc 55929
- Oxacyclotetradecane, erythromycin deriv.
- Oxacyclotetradecane-2,10-dione, 4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-<span class="text-smallcaps">L</smallcap>-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-<smallcap>D</span>-xylo-hexopyranosyl]oxy]-, [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-
- Oxacyclotetradecane-2,10-dione, 4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-
- P.C.E.
- PCE
- Pantomicina
- Pediamycin
- Retcin
- Robimycin
- Statcin
- Staticin
- Stiemycin
- T-Stat
- Theramycin Z
- Torlamicina
- Torlamicna
- Vetwic
- Wintrocin
- Wyamycin-s
- [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-<span class="text-smallcaps">L</smallcap>-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-<smallcap>D</span>-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione
- [3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)]-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione
- Erythromycin
